Measures of Comorbidities and Frailty in Multiple Sclerosis—Systematic Review on Evidence and Applicability of Utilized Scoring Systems in Clinical Routine and Real‐World Data

In multiple sclerosis (MS), comorbidities and frailty are receiving increasing attention influencing disease course, treatment and quality of life. The objective of this literature review is to evaluate the evidence, strengths and weaknesses of assessment tools for comorbidities and frailty in people with MS (pwMS).

• Publication year

  2025

• Venue

  European Journal of Neurology

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ene.70425PMID 41208691PMCID 12598409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measures of Comorbidities and Frailty in Multiple Sclerosis—Systematic Review on Evidence and Applicability of Utilized Scoring Systems in Clinical Routine and Real‐World Data

  2025cited by this paper
• Comorbidity and Disease Activity in Multiple Sclerosis

  2024cited by this paper
• Frailty in multiple sclerosis: A scoping review.

  2024cited by this paper
• Concomitant autoimmunity and risk of multiple sclerosis disability worsening.

  2024cited by this paper
• Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review.

  2024cited by this paper
• Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

  2024cited by this paper
• Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study

  2023cited by this paper
• Early depressive symptoms and disability accrual in Multiple Sclerosis: a UK MS Register study

  2023cited by this paper
• Etiology, effects and management of comorbidities in multiple sclerosis: recent advances

  2023cited by this paper
• Comorbid conditions and physical function in adults with multiple sclerosis.

  2023cited by this paper
• Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study

  2023cited by this paper
• Combining the Hospital Frailty Risk Score With the Charlson and Elixhauser Multimorbidity Indices to Identify Older Patients at Risk of Poor Outcomes in Acute Care

  2023cited by this paper
• Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study

  2023cited by this paper
• Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study

  2023cited by this paper
• Switching to second line MS disease-modifying therapies is associated with decreased relapse rate

  2023cited by this paper
• Association between frailty and sleep quality in people living with multiple sclerosis and obesity: An observational cross-sectional study.

  2023cited by this paper
• Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease

  2023cited by this paper
• Multidimensional frailty and its association with quality of life and disability: A cross-sectional study in people with multiple sclerosis.

  2023cited by this paper
• Frailty and relapse activity in multiple sclerosis: A longitudinal observation.

  2023influential reference
• The Association Between the Clinical Frailty Scale and Adverse Health Outcomes in Older Adults in Acute Clinical Settings – A Systematic Review of the Literature

  2023cited by this paper
• Association Between Frailty and Free-Living Walking Performance in People With Multiple Sclerosis.

  2023cited by this paper
• The Tilburg Frailty Indicator: A Psychometric Systematic Review.

  2022cited by this paper
• Frailty among people with multiple sclerosis who are wheelchair users

  2022cited by this paper
• Frailty: A Multidimensional Biopsychosocial Syndrome.

  2022cited by this paper
• Charlson Comorbidity Index: A Critical Review of Clinimetric Properties

  2022cited by this paper
• Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis

  2022cited by this paper
• Frailty and falls in people living with multiple sclerosis.

  2021cited by this paper
• Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation

  2021influential reference
• Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients

  2021cited by this paper
• Colorectal Cancer Survival in Multiple Sclerosis

  2021cited by this paper
• Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality

  2021cited by this paper
• Prescribing of disease modifying agents in older adults with multiple sclerosis.

  2021cited by this paper
• Validity and reliability of Fried frailty phenotype in Turkish population

  2021cited by this paper
• Predictors of hospitalization in a Canadian MS population: A matched cohort study.

  2020cited by this paper
• Frailty in ageing persons with multiple sclerosis

  2020cited by this paper
• Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis.

  2020cited by this paper
• The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study

  2020cited by this paper
• Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records.

  2020cited by this paper
• A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications

  2020cited by this paper
• Characterization of Models for Identifying Physical and Cognitive Frailty in Older Adults With Diabetes: Systematic Review and Meta-Analysis

  2020cited by this paper
• Cross-sectoral inter-rater reliability of the clinical frailty scale – a Danish translation and validation study

  2020cited by this paper
• The Tilburg Frailty Indicator (TFI): New Evidence for Its Validity

  2020cited by this paper
• Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS.

  2019cited by this paper
• Disability worsening among persons with multiple sclerosis and depression

  2019cited by this paper
• Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation.

  2019cited by this paper
• Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality

  2019cited by this paper
• Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study

  2018cited by this paper
• Health Outcomes and Lifestyle in a Sample of People With Multiple Sclerosis (HOLISM): Longitudinal and Validation Cohorts

  2018cited by this paper
• Temporal trends in multiple sclerosis prevalence and incidence in a large population

  2018cited by this paper
• Psychiatric comorbidity is associated with disability progression in multiple sclerosis

  2018cited by this paper
• Assessing association of comorbidities with treatment choice and persistence in MS

  2017cited by this paper
• Comorbidity in multiple sclerosis: implications for patient care

  2017cited by this paper
• Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index

  2017cited by this paper
• Exploring the efficiency of the Tilburg Frailty Indicator: a review

  2017cited by this paper
• The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records

  2017cited by this paper
• Social frailty in older adults: a scoping review

  2017cited by this paper
• Comorbidity increases the risk of relapse in multiple sclerosis

  2017cited by this paper
• Effects of Specialty Pharmacy Care on Health Outcomes in Multiple Sclerosis.

  2016cited by this paper
• Validating a Patient-Reported Comorbidity Measure with Respect to Quality of Life in End-Stage Renal Disease

  2016cited by this paper
• Recommendations for observational studies of comorbidity in multiple sclerosis

  2016cited by this paper
• Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

  2016cited by this paper
• Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis

  2016cited by this paper
• Frailty measurement in research and clinical practice: A review.

  2016influential reference
• Health-related quality of life in multiple sclerosis

  2016cited by this paper
• Sex differences in comorbidity at diagnosis of multiple sclerosis

  2016cited by this paper
• Psychometric properties of multicomponent tools designed to assess frailty in older adults: A systematic review

  2016cited by this paper
• Association of the clinical frailty scale with hospital outcomes.

  2015cited by this paper
• Effect of comorbidity on mortality in multiple sclerosis

  2015cited by this paper
• A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

  2015cited by this paper
• Frailty in an Older Inpatient Population

  2015cited by this paper
• A systematic review identifies valid comorbidity indices derived from administrative health data.

  2015cited by this paper
• Validity of the modified Charlson Comorbidity Index as predictor of short-term outcome in older stroke patients.

  2015cited by this paper
• Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis

  2014cited by this paper
• Screening for frailty in primary care: a systematic review of the psychometric properties of the frailty index in community-dwelling older people

  2014cited by this paper
• The prediction of quality of life by physical, psychological and social components of frailty in community-dwelling older people

  2014cited by this paper
• Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics

  2013cited by this paper
• Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) International Consensus Group

  2013cited by this paper
• Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months.

  2013cited by this paper
• Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly?

  2012cited by this paper
• A comparison of physical activity (PA) assessment tools across levels of frailty.

  2012cited by this paper
• Association between comorbidity and clinical characteristics of MS

  2011cited by this paper
• GRADE guidelines: 3. Rating the quality of evidence.

  2011cited by this paper
• The frailty syndrome: definition and natural history.

  2011cited by this paper
• The Tilburg Frailty Indicator: psychometric properties.

  2010cited by this paper
• Comorbidities amongst patients with multiple sclerosis: a population‐based controlled study

  2010cited by this paper
• Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis

  2010cited by this paper
• A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data

  2009cited by this paper
• Comorbidity delays diagnosis and increases disability at diagnosis in MS

  2009cited by this paper
• The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients.

  2008cited by this paper
• A standard procedure for creating a frailty index

  2008cited by this paper
• Stroke: The Elixhauser Index for comorbidity adjustment of in-hospital case fatality

  2008cited by this paper
• Frailty in relation to the accumulation of deficits.

  2007cited by this paper
• A global clinical measure of fitness and frailty in elderly people

  2005cited by this paper
• A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research.

  2005cited by this paper
• Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

  2005cited by this paper
• Relative Fitness and Frailty of Elderly Men and Women in Developed Countries and Their Relationship with Mortality

  2005influential reference
• Inter-rater reliability and annual rescoring of the Charlson comorbidity index.

  2004cited by this paper
• The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research.

  2003cited by this paper
• Frailty, fitness and late-life mortality in relation to chronological and biological age

  2002influential reference
• Frailty in older adults: evidence for a phenotype.

  2001cited by this paper

• Measures of Comorbidities and Frailty in Multiple Sclerosis—Systematic Review on Evidence and Applicability of Utilized Scoring Systems in Clinical Routine and Real‐World Data

  2025cites this paper